NCBiotech News

Durham-based Chimerix has gotten the green light from the FDA to test an investigational cancer drug to treat COVID-19 patients.

NCBiotech awarded 13 grants and loans totaling $1.8 million to universities and bioscience companies in the third quarter of its current fiscal year.

Four North Carolina universities have teamed up to win a $5.7 million federal grant for diabetes research.

CED's Venture Connect Online starts today and runs for the next three weeks, giving over 90 growth-stage companies exposure to potential investors from around the world.

People who have recovered from COVID-19 may donate potentially lifesaving plasma at UNC, and Grifols is also collecting it at plasma donor sites elsewhere around the country.

Banner Life Sciences, a High Point pharmaceutical company, has gained final regulatory approval of a drug for treating multiple sclerosis.

Durham-based Chimerix is another step closer to getting the final go-ahead for its novel smallpox treatment.

For those feeling the health and economic heat from COVID-19 – and that’s just about everyone – Heat Biologics says it could soon offer up a potential solution.

First Flight Venture Center has named Krista Covey as the incubator’s new president, effective May 18. 

Duke University biomedical engineers are using an NSF grant to convert a rapid testing platform originally designed to detect Ebola to catch antigens to COVID-19.

RedHill Biopharma, an Israeli specialty company with U.S. headquarters in Raleigh, says all six COVID-19 patients who recently received its investigative drug, opaganib, got better. 

Wake Forest University researchers have a $3 million NSF grant to study why tomato plants won’t bear fruit when things get hot.

Morrisville precision health company Metabolon is working with a Seattle non-profit to study variations in COVID-19 outcomes and target potential therapies to deal with those variations.

AskBio has acquired BrainVectis, a French company that is developing a potential gene therapy for Huntington’s disease, a fatal genetic disease of the brain.

Healthcare workers and first responders who have symptoms of COVID-19 now can use a LabCorp kit to self-test for the coronavirus at home.